Coronavirus pharma conference monitor – event impact of COVID-19

The COVID-19 coronavirus epidemic that originated in Wuhan, the capital of China’s Hubei province, has wide-ranging implications for the pharmaceutical industry and healthcare sector alike.

The US Food and Drug Administration (FDA) has already warned of the first drug shortage caused by COVID-19 and the impact of China’s measures to slow infections of the virus on its API manufacturing sector remains to be seen.

29

CANCELLED

EVENTS

36

DELAYED

EVENTS

15

DIGITISED

EVENTS

02

AS PLANNED

EVENTS

Jump to pharmaphorum’s coronavirus pharma conference and event monitor

Pharma research into COVID-19 coronavirus

Several pharma companies have been active on the research front, with AbbVie moving quickly to offer the Chinese government supplies of its Kaletra/Aluvia (lopinavir/ritonavir) as an experimental treatment option back in January.

Gilead, Johnson & Johnson, Sanofi, Takeda, GSK and Moderna are also among the pharma companies rushing to develop potential therapies for COVID-19 coronavirus.

Meanwhile, Roche’s already-marketed anti-inflammatory drug Actemra (tocilizumab) has already been approved for emergency use in China in patients whose lungs are failing following COVID-19 infection.

Microscopic view of Coronavirus

Microscopic view of Coronavirus, a pathogen that attacks the respiratory tract. Analysis and test, experimentation. Sars. 3d render

COVID-19 coronavirus disruption and the pharmaceutical industry

Despite the industry’s best intentions there are concerns the COVID-19 outbreak may disrupt research, preventing patients traveling to clinical trial sites and reducing the resources available for R&D.

Aiming to ease some of those pressures,  the EU’s Innovative Medicines Initiative (IMI) is offering €45 million (around $50 million) in R&D funding for promising coronavirus research and a consortium led by the Bill & Melinda Gates Foundation has committed $125 million to speed up access to drugs to treat the coronavirus epidemic.

Pharma event attendance and medical conferences

In addition to country-level effects to contain the virus, pharmaceutical companies are moving to restrict travel.

This has a significant effect for pharma industry and medical conference attendance, which is already dropping, with a number of events being cancelled, postponed or switched to an all-digital format.

For those thinking of attending a pharma industry or medical conference in the coming weeks, pharmaphorum has compiled a list of which events have been cancelled or delayed, and which have said they are still going ahead.

While the list is not exhaustive, pharmaphorum will monitor the situation each day and post updates on this page.

  • If you are an event organiser and would like to alert pharmaphorum’s team to any changes because of the coronavirus, please email editorial@pharmaphorum.com.

Last updated 14/04/2020

 

Cancelled events – 29

Cannes Lions, Cannes, France 26-30 October

The American Academy of Allergy, Asthma & Immunology, AAAAI, Philadelphia, US
13-16 March

South by Southwest, or SXSW, Austin, Texas, US
13-22 March

International Conference on medical and health science, Kiev, Ukraine
16-18 March

Food Ingredients China, FIC, Shanghai, China
17-19 March

American College of Medical Genetics and Genomics, or ACMG, San Antonio, Texas, US
17-21 March

The American Chemical ACS, Philadelphia, US
22-26 March

Congress on Healthcare Leadership, The American College of Healthcare Executives, Chicago, US
23-26 March

The Drug, Chemical & Associated Technologies Association, DCAT, New York, US
23-26 March

The American Medical Informatics Association, AMIA, Houston, US
23-26 March

The Virtual Medicine conference,  vMed, Cedars-Sinai Medical Center, Los Angeles, US
25-26 March

American College of Cardiology’s and World Congress of Cardiology’s 69th Annual Scientific session, Chicago, US
28-30 March

The Endocrine Society’s annual meeting (ENDO), San Francisco,  US
28-31 March

Parenteral Drug Association, PDA Annual Meeting, Raleigh, US
30 March – 1 April

Microbiology Society Annual Conference, Edinburgh, Scotland
30 March – 3 April

Phar-East, Singapore
31 March – 1 April

In-Cosmetics Global, Barcelona, Spain
31 March – 2 April

Medteclive, Nuremberg, Germany
31 March – 2 April

Analytica, Munich, Germany
31 March – 3 April

The Experimental Biology conference, EB, San Diego, US
4-7 April

Pharmaconex, Cairo, Egypt
5-7 April

Pharmchina 2020, Shanghai, China
8-10 April

eHealth Week, Rovinj, Croatia
15-17 April

Cosmofarma Exhibition, Bologna, Italy
17-20 April

Faculty of Medical Psychotherapy Annual Conference, Oxford, UK
(Original dates 22-24 April)

2020 AAN Annual Meeting, Toronto, Canada
25 April – 1 May

Medical Informatics Europe, Geneva, Switzerland
Original dates 28 April – 1 May

International Conference on Medical & Health Science, Kuala Lumpur, Malaysia
1-2 May

Infection Prevention and Control (IPAC) Canada – 2020 National Education Conference, Winnipeg, Canada
3 – 6 May

 

Delayed events – 36

 

World Patient Safety, Science & Technology Summit, Los- Angeles, US
(Original date 5-7 March) new date TBC

Novel antimicrobials and AMR Diagnostics, Basel, Switzerland
(Original date 12-13 March) Postponed until 24-25 August

Asia Pacific Breast Cancer Summit, Singapore
(Original date 13-15  March) new date TBC

Antibody Biology and Engineering GRC/GRS, CA, US
(Original dates 14-20 March) Postponed until 17- 23 April 2021

DIA Europe 2020, Brussels, Belgium
(Original date 17-19 March) Postponed until 30 June – 3 July

Pharma Pricing, Market Access and Evidence Congress, Amsterdam, Holland
(Original date 18-19 March) Postponed until 24-25 September

National Comprehensive Cancer Network, NCCN
(Original date 19-22 March ) new date TBC

WIRED Health, London, UK
(Original date 25 March) Postponed 31 March 2021

Binaytara Foundation Summit on National and Global Cancer Health Disparities, Bellevue, US
(Original date 3-4 April ) new date TBC

The Medical Affairs Strategic Summit East 2020 (MASS), New Brunswick, New Jersey, US
(Original dates 14-16 April) New date TBC

Digital Health for Pharma, Philadelphia, US
(Original dates 20 -22 April) New date TBC

The Symposium on Artificial Intelligence for Learning Health Systems, SAIL, Bermuda
(Original date 27-29 April) new date TBC

Pharmaceutical Compliance Congress (PCC) 2020, Washington, DC, US
(Original dates 29 April – 1 May) New date TBC

Pharmaceutical Compliance Congress, Washington DC, U.S.
(Original dates 29 April – 1 May) new dates TBC

Public Health Conference, Cortland US
(Original dates 30 April – 1 May) New dates TBC

NEW –  The annual Infection Prevention and Control Conference, London, UK
(Original date 30 April) New date 14 January 2021

Next Pharma Summit, Dubrovnik, Croatia
(Original date 6-7 May) Postponed until 29-30 September

The Conference on Research in Computational Molecular Biology RECOMB, Padova, Italy
(Original date 10-13 May) new date TBC

2020 ESH-ISH Glasgow Meeting, UK
(Original dates 29 May – 1 June, 2020) Postponed, new date TBC

The ASCO Annual Meeting, Chicago, US
(Original dates 29 May – 2 June) New dates TBC

Medforce, Berlin, Germany
(Original date 9-10 June) new date 20-21 October

Al in Pharmaceuticals Summit, Boston, US
(Original dates 18 – 19 June) New dates 25 – 26 March 2021

CPhI South East Asia, Bangkok, Thailand
Postponed until 1-3 July

World Orphan Drug Congress, Maryland, US
Delayed until August 24-26

WIP 2020, Rome, Italy
Postponed till 26-29 August

World Drug Safety Congress Americas 2020
Postponed until 1-2 September

CPhI North America, Pennsylvania, US
Postponed until  9-11 September

18th Biosimilar Medicines Conference, Amsterdam, Netherlands
Postponed until 17-18 September

Legal Affairs Conference, London, UK
Postponed until 28-29 September

CPhI Japan, Osaka, Japan
Postponed until 30 September – 2 October

The RE(ACT) Congres
Postponed to 13-16 January 2021

Celtic conference – Pharmacy Management, Cardiff, UK
Postponed until March 2021

Medidata Next London, UK
Postponed, new date TBC

Merck Group, Annual General Meeting, Frankfurt am Main, Germany
Postponed, new date TBC

American Association for Cancer Research, (AACR), San Diego, US
Postponed, new date TBC

 

Digitalised – 15

11th Annual Congress on Pulmonology & Respiratory Medicine, Amsterdam, Netherlands
18-19 March – now running as a webinar

2020 HIMSS Global Health Conference & Exhibition, Orlando, US
9-13 March
Physical event cancelled and special digital edition planned with the goal of making all of the HIMSS20 sessions and panels available online.

Conference on Retroviruses and Opportunistic Infections (CROI), Boston, US
8-11 March
Physical event cancelled and is being delivered digitally from 8 March

Barclays – Global healthcare conference, Miami, Florida, US
10-12 March
Physical event cancelled and is being delivered digitally from 10 March.

The Cognitive Neuroscience Society (CNS), Boston, US
14- 17 March
Physical event cancelled and is being delivered digitally from 14 March

Y Combinator’s biannual Demo Day
23-24 March
Physical event cancelled and is being delivered digitally from 23 March

BIO-Europe Spring, Paris, France
23-25 March.
Physical event cancelled and is being delivered digitally from 23 March with online panels, presentations and exhibitions

eyeforpharma Barcelona, Spain
31 March – 2 April

eyeforpharma Philadelphia, US
15-16 April

16th Annual meeting of International Society for Medical Publications Profession (ISMPP)
(Original dates 20 – 22 April) New dates 16 – 18 June

BioTrinity, London, UK
28-29 April

Veeva R&D Summit, Barcelona, Spain
18-20 May

PharmaVenue, Madrid, Spain
May 25-26, 2020

World Congress of Bioethics, The International Association of Bioethics, Philadelphia, US
19-21 June

PM Society Digital Awards
17 September

 

Going ahead as planned – 2

 

80th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Seville, Spain
13-17 September 2020

Pharmatec Series, London, UK
24-25 September